These laws, pushed through the WTO by the industry, force developing nations to adhere to Western pharmaceutical patents—and to accept high Western prices. These patents protect high corporate profits, but allow pricing above what the populace of countries like Thailand, Sudan, the Democratic Republic of the Congo, and Brazil can afford. They also allowed companies to abandon the development of medications they deem unprofitable, often medicines intended for
